All GLG News Analyses Filed Under: Business of Medicine
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
-
Is the Controversy over the Public Option the biggest Red Herring Ever?
November 20, 2009
Reid Pushes for Votes on Health-Care Bill | www.washingtonpost.com
Nothing has raised the hackles of partisan Democrats and especially Republicans more this year than the public health insurance option. On the left, liberals consider it to be the indispensable component of true healthcare reform. On the right, conservatives refer to it to the first step on the slippery slope to socialism, if not a return to the Third Reich this time in America. Yet, the truth is that its impact will likely be so small, its presence (or absence) hardly merits any debate.
-
Will Bundles of Healthcare Payments Bring Joy to Anybody?
November 13, 2009
RAND: Bundled Payments the Best Way to Contain Healthcare Costs | www.fiercehealthcare.com
Analysts at RAND Corp. have thrown their weight behind the use of bundled fees to pay physicians and hospitals. They have concluded that although difficult to implement, doing so is probably the most effective way to contain health care costs which could spin even more out of control under the current health care reform proposals and ultimately bankrupt the federal government without dramatic changes to the current fee for service system.
-
Novartis, Sleeping Giant Wakes-Up in China
November 6, 2009
Novartis to invest US$ 1 bn to build largest pharma R&D institute in China | www.pharmabiz.com
Novartis to grow its China presence, late.Novartis has a slow response to market opportunities.GlaxoSmithKline and other big pharma players are perhaps too large to compete in the world's changing markets.
-
Ken PowellPresidentGenesis Business Development, LLC
FDA Publishes H1N1 Diagnostic Test Guidance
November 5, 2009
FDA Publishes Guidance Document for H1N1 Dx | www.genomeweb.com
The FDA published document designed to help diagnostic test manufactures develop H1N1 tests and data that would accompany a FDA application to market them. This follows on the recent issuance of CDC guidelines for H1N1 tests.
-
November 3, 2009
Deficit Plays into Health Reform | www.washingtonpost.com
There is no doubt that a great deal of time, efforts and resources have gone into trying to find a solution to the healthcare problems and concerns that we deal with today. What is not as clear to those who really need these problems solved are the answers thus far. A lot of very smart people seem to have forgotten the actual value of a person. What ever numbers show up on the balance sheet hardly provides any direction to those who care more about dollars and cents than common sense.
-
Pharma Outsourcing: Where Will it End?
November 3, 2009
Quintiles inks pharma deals | www.outsourcing-pharma.com
A major supplier of clinical development services has just been awarded all of Astra Zeneca's clinical pharmacology work. Such work was traditionally performed internally but is now one of many stages of development being outsourced. This follows similar trends in research, where pharma companies are forging external relationships. We question where the pharma industry is headed and how much of its core business will remain in-house.
-
ASTRO/ACRO help win the fight against Reimbursement Cuts for Radiation Oncology
November 2, 2009
CMS announcement regarding Radiation Oncology Reimbursement for 2010 | cs.astro.org
Major news breaking.. CMS has decided to implement only a 1% cut annually for radiation oncology reimbursement. This may be the most important news item in the world of oncology for the past decade. Faced with untenable projected cut of 19%, CMS reversed course and reduced the reduction in payment.
-
It's Time for Health Care Reform--Not Just Health Insurance Reform!
October 30, 2009
The Health Care Reform Debate We Need | blog.nj.com
With so much emphasis on changing the health insurance system, the far greater need to change the delivery and financing of care has gotten relatively little mention, at least in the sound bites where most people receiving their daily news. We should not squander this once in a lifetime change for real health care, and not just health insurance reform.
-
Shares That Go Bump In The Night
October 30, 2009
Transcept Pharma sleep drug denied approval, shrs sink | www.reuters.com
Transcept is developing Intermezzo for Middle of Night Insomnia. Intermezzo is low dose zolpidem (same chemical as Ambien). FDA's questions delay access to the $7 billion US sleep disorder market. Transcept's shares dropped dramatically on the news
-
October 27, 2009
Indus Biotech develops drug to control HIV/AIDS | www.pharmabiz.com
This is indeed great news for HIV sufferers all over the world. Since the drug is derived from botanical sources, the cost will be within the reach of millions in the developing world. It will also help those infected with HIV in the developed world where the cost of conventional therapies are extremely high.Ashok Bendre
- Subscribe to Updates
-
Leading institutions connect with members of the Healthcare councils through GLG
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 7 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Most Popular Business of Medicine News
-
Pharma Outsourcing: Where Will it End?
November 3, 2009
-
What does Solvay offer to a bidder ?
September 25, 2009
-
Talecris Biotherapeutics Proposes IPO; Hits Favorable Timing Window
September 23, 2009
-
Health Care Reform Debate 2009 ~ Blind Rush to Rash Decisions
September 23, 2009
-
Why Health Care Costs Keep Rising—And What to Do About It
September 13, 2009